Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


Proteins & Biopharma Asia Congress

10 Sep 2012 - 11 Sep 2012 - Singapore



Bookmark and Share


Over 175 attendees working within proteins, antibodies and biotherapeutics research, upstream & downstream processing in Asia

Over 40 case studies, presentations and panel discussions

4 interactive streams:

  • Upstream:  Cell Culture
  • Downstream: Protein Purification, Expression & Characterisation
  • Biotherapeutics
  • Bioprocessing & biopharmaceutical manufacturing

14 prescheduled one to one business meetings & exhibitions

Oxford Global Conferences is proud to present the Proteins & Biopharma Asia Congress 2012, which is to be held on the 10th & 11th September in Singapore. The congress is the single most focused event in Asia Pacific dedicated to key technological and scientific trends in the Asia Biopharmaceutical industry.

The biopharmaceutical market for Asia Pacific revenues is estimated to be around US$ 5.7 billion (2010), with average annual growths rates around 10.3%. This high growth is creating a strong need for production of biopharmaceuticals at higher qualities and volumes as well as developing an effective and efficient bioprocess. The biopharmaceutical industry – antibodies & antibody alternatives, therapeutic Proteins, Antibodies and vaccines – promises success in overcoming these challenges. The Proteins & Biopharma Asia Congress seeks to address the current trends and technologies in advancing upstream and downsteam bioprocesses of proteins, antibodies and vaccines. It will also address the current developments in Protein and Antibody biotherapeutics research, purification & expression systems and recombinant protein therapeutics. Proteins & Biopharma Asia Congress brings together global leaders within biopharmaceutical industry to explore the dynamic strategies, benchmark the latest technologies and offer insights into accelerating growth in the industry.

Over two days, this event will attract over 175 senior-level decision makers working in upstream and downstream production from Asia Pacific. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.



Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!